Eastwood Bio-Medical Canada Inc

Research Eastwood Bio-Medical Canada Inc (EBM) on Bullrun: market cap CAD 134.33M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CAD 134.33M.

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-06CAD 134.33Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 CAD.

About Eastwood Bio-Medical Canada Inc

Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance;

Related stock research

Other Consumer Defensive stocks

Frequently asked questions

What is Eastwood Bio-Medical Canada Inc's market cap?

Eastwood Bio-Medical Canada Inc's market capitalization is CAD 134.33M.

What does Eastwood Bio-Medical Canada Inc do?

Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity.